Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023

GBD 2023 Breast Cancer Collaborators

doi:10.1016/S1470-2045(25)00730-2

The Lancet. Oncology, 27(3), 302-326, 2026

Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023

GBD 2023 Breast Cancer Collaborators

DOI10.1016/S1470-2045(25)00730-2 PMID41785894

Read at source

Abstract

No abstract available for this article.

Topics

General OB/GYN > Oncology > Breast Cancer Epidemiology Research Methodology > Systematic Reviews > Global Burden of Disease

global breast cancer burden 1990-2023, GBD 2023 breast cancer incidence mortality, breast cancer epidemiology developing countries, female breast cancer forecasts 2050, regional breast cancer mortality trends, breast cancer DALYs systematic analysis, Global Burden of Disease breast cancer, breast cancer incidence age-standardized rates, women's cancer global health burden, breast cancer prevention population-level data

PMID 41785894 41785894 DOI 10.1016/S1470-2045(25)00730-2 10.1016/S1470-2045(25)00730-2

Cite this article

GBD 2023 Breast Cancer Collaborators (2026). Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet Oncology*, *27*(3), 302-326. https://doi.org/10.1016/S1470-2045(25)00730-2

Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023

Abstract

Topics

Cite this article

Related articles

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies